We examine the impact of major global companies in Switzerland and internationally, with a primary focus on key Swiss industries: pharma, healthcare, food, and agribusiness.
More
How Novartis got ahead on ‘incredible’ cancer breakthrough
This content was published on
The Swiss pharma group has become a pioneer in a new type of targeted radiotherapy.
This content was published on
Ypsomed CEO explains why US tariffs are not a worry and why he sees more growth from diabetes and obesity treatments such as Ozempic.
When diagnosing a disease does more harm than good
This content was published on
Switzerland has the highest number of MRI scanners per person in Europe. But more screening doesn’t always lead to better health outcomes.
Potential US tariff exemption for Swiss pharma is not necessarily a boon
This content was published on
Donald Trump is pressuring the pharma industry with tariffs. But experts say that tariffs will have less impact on the industry than pricing.
Can Saudi Arabia’s billions unlock the secrets to a longer, healthier life?
This content was published on
Longevity has been an underfunded area of biotech research but that is changing thanks to an unlikely source: Saudi Arabia.
How US tariffs could disrupt the generic drugs supply chain
This content was published on
US tariffs on generics could raise drug prices and accentuate shortages. That’s not what US President Donald Trump had in mind.
When diagnosing a disease does more harm than good
This content was published on
Switzerland has the highest number of MRI scanners per person in Europe. But more screening doesn’t always lead to better health outcomes.
Can Saudi Arabia’s billions unlock the secrets to a longer, healthier life?
This content was published on
Longevity has been an underfunded area of biotech research but that is changing thanks to an unlikely source: Saudi Arabia.
Global concern over measles is rising. Should Switzerland worry?
This content was published on
Measles is making a global comeback. In Switzerland, a crisis is unlikely – but authorities warn a strong vaccination rate remains crucial.
This content was published on
Nearly 30 years ago an academic paper wrongly linked autism to a measles vaccine. The impacts are still being felt today.
Novartis bets on ageing as next frontier in drug development
This content was published on
Swiss pharma giant Novartis is diving into research on ageing to tap the growing market for drugs that help keep older adults healthy.
Chinese biotechs eye Swiss collaboration as relations with US sour
This content was published on
With growing uncertainty in the US, Chinese companies are swooping in to present themselves as stable, open partners to the Swiss biotech sector.
Why bird flu could threaten traditional Swiss cheeses
This content was published on
Switzerland’s cows have dodged the global H5N1 bird flu so far. But if it hits dairy herds, the country’s iconic cheeses could be at risk.
This content was published on
A new food agreement with the EU opens up export opportunities for Swiss agriculture – but it also sets some alarm bells ringing for farmers.
US consumers will pay price for tariff hike, warns top Swiss trader
This content was published on
Global competition is on the rise and some low value-added activities have already left Switzerland, warns Sébastien Landerretche.
Does your country have enough food reserves to withstand a crisis?
This content was published on
Despite the increasing risks of war, unpredictable weather and economic shocks to food security, only 30 countries are actively using grain reserves. Switzerland is one of them.
Truth or tale: is Swiss chocolate tainted by child labour?
This content was published on
A reader asked if it was true that children are involved in cocoa production for the Swiss chocolate industry. Swissinfo tried to get to the bottom of this complex issue.
Child labour risks in chocolate supply chains go beyond just cocoa
This content was published on
While cocoa gets the most attention from the chocolate industry when it comes to eliminating child labour, other ingredients like sugar, nuts or vanilla are also high risk.
Dubai chocolate trend leaves Swiss chocolatiers competing for pistachios
This content was published on
The TikTok-fuelled popularity of Dubai chocolate has prompted Swiss chocolate companies to develop their own versions, spiking demand for pistachios.
Swiss food labels must declare animal suffering from July
This content was published on
From July 1, food labels in Switzerland will have to disclose whether products of animal origin involve painful practices. The Swiss federal government has approved a series of ordinances requiring the labelling of meat, eggs and foie gras.
Ukraine’s once pioneering agriculture drone industry is hoping to return to the skies
This content was published on
Restrictions due to the war have killed off growth in an industry that is hoping for a renaissance once the fighting is over.
Truth or tale: is Swiss chocolate tainted by child labour?
This content was published on
A reader asked if it was true that children are involved in cocoa production for the Swiss chocolate industry. Swissinfo tried to get to the bottom of this complex issue.
This content was published on
People have come to Switzerland for centuries in search of the fountain of youth. How did the country become a magnet for longevity seekers?
Lost stem cells: the scandal of a Swiss cord blood bank
This content was published on
Imagine placing all your hopes on your baby’s stem cells to save their life or yours, only to fear seeing that hope vanish along with your child’s cells.
What the Swiss don’t know about sexually transmitted infections
This content was published on
Many Swiss are not that savvy about sexually transmitted infections. Even so, a programme to inform people about STIs is being cut.
Swiss pharma reckons with its past, present and future
This content was published on
This is the story of how making drugs helped turn a small, mountainous country into an industry titan, and what the pandemic means for its future.
This content was published on
Ypsomed CEO explains why US tariffs are not a worry and why he sees more growth from diabetes and obesity treatments such as Ozempic.
When diagnosing a disease does more harm than good
This content was published on
Switzerland has the highest number of MRI scanners per person in Europe. But more screening doesn’t always lead to better health outcomes.
Why bird flu could threaten traditional Swiss cheeses
This content was published on
Switzerland’s cows have dodged the global H5N1 bird flu so far. But if it hits dairy herds, the country’s iconic cheeses could be at risk.
This content was published on
A new food agreement with the EU opens up export opportunities for Swiss agriculture – but it also sets some alarm bells ringing for farmers.
US consumers will pay price for tariff hike, warns top Swiss trader
This content was published on
Global competition is on the rise and some low value-added activities have already left Switzerland, warns Sébastien Landerretche.
Potential US tariff exemption for Swiss pharma is not necessarily a boon
This content was published on
Donald Trump is pressuring the pharma industry with tariffs. But experts say that tariffs will have less impact on the industry than pricing.
Does your country have enough food reserves to withstand a crisis?
This content was published on
Despite the increasing risks of war, unpredictable weather and economic shocks to food security, only 30 countries are actively using grain reserves. Switzerland is one of them.
Truth or tale: is Swiss chocolate tainted by child labour?
This content was published on
A reader asked if it was true that children are involved in cocoa production for the Swiss chocolate industry. Swissinfo tried to get to the bottom of this complex issue.
Can Saudi Arabia’s billions unlock the secrets to a longer, healthier life?
This content was published on
Longevity has been an underfunded area of biotech research but that is changing thanks to an unlikely source: Saudi Arabia.
How US tariffs could disrupt the generic drugs supply chain
This content was published on
US tariffs on generics could raise drug prices and accentuate shortages. That’s not what US President Donald Trump had in mind.
Sandoz board chair ‘convinced that common sense will ultimately prevail’ on US pharma tariffs
This content was published on
In an exclusive interview with Swissinfo, Sandoz chair Gilbert Ghostine says he remains optimistic despite looming tariff hikes.
Child labour risks in chocolate supply chains go beyond just cocoa
This content was published on
While cocoa gets the most attention from the chocolate industry when it comes to eliminating child labour, other ingredients like sugar, nuts or vanilla are also high risk.
Dubai chocolate trend leaves Swiss chocolatiers competing for pistachios
This content was published on
The TikTok-fuelled popularity of Dubai chocolate has prompted Swiss chocolate companies to develop their own versions, spiking demand for pistachios.
Ukraine’s once pioneering agriculture drone industry is hoping to return to the skies
This content was published on
Restrictions due to the war have killed off growth in an industry that is hoping for a renaissance once the fighting is over.
Global concern over measles is rising. Should Switzerland worry?
This content was published on
Measles is making a global comeback. In Switzerland, a crisis is unlikely – but authorities warn a strong vaccination rate remains crucial.
This content was published on
Nearly 30 years ago an academic paper wrongly linked autism to a measles vaccine. The impacts are still being felt today.
Rare diseases take centre stage at global health summit
This content was published on
Rare diseases have been recognised as a global health priority for the first time. How could this impact access to life-saving treatment?
Novartis bets on ageing as next frontier in drug development
This content was published on
Swiss pharma giant Novartis is diving into research on ageing to tap the growing market for drugs that help keep older adults healthy.
Despite Trump’s bold claims, medicine prices in Europe won’t rise anytime soon
This content was published on
US President Trump has taken aim at Europe for undercharging for medicine. But raising prices in Europe would face strong pushback.
Chinese biotechs eye Swiss collaboration as relations with US sour
This content was published on
With growing uncertainty in the US, Chinese companies are swooping in to present themselves as stable, open partners to the Swiss biotech sector.
The Basel researcher whose work triggered a longevity revolution
This content was published on
Basel-based scientist Michael Hall’s discovery of the gene Target of Rapamycin has fuelled one of the fastest growing trends – longevity.
This content was published on
People have come to Switzerland for centuries in search of the fountain of youth. How did the country become a magnet for longevity seekers?
Longevity clinics: modern-day snake oil or the key to healthy ageing?
This content was published on
Scientists have yet to find the elixir of life but this hasn’t stopped longevity clinics from selling treatments, pills and gadgets that claim to slow ageing.
This content was published on
Looming US pharma tariffs could challenge the status quo in pharmaceutical hubs like Switzerland as investment shifts to the US.
